Vial is Scaling AI Designed Drugs to Cure Disease
We are advancing AI designed drugs at an unprecedented scale by leveraging automated labs and clinical trials.
AI Designed Therapeutics
AI-Driven Target Discovery
Vial’s integrated models analyze massive multi-omic and clinical datasets to identify high-value therapeutic targets with unprecedented speed and resolution.
Automated Molecule Design
Our platform generates, evaluates, and optimizes drug candidates through iterative AI-driven design loops, reducing timelines from months to days.
Rapid Experimental Validation
Vial’s automated wet-lab workflows and high-throughput assays validate AI-designed compounds quickly, enabling faster prioritization and clinical translation.
Vial’s automated R&D pipeline brings molecular designs to life, producing and testing therapeutic candidates with unprecedented speed, consistency, and throughput
- AUTOMATED LABS
Automated Clinical Trials
- MASSIVE SCALE
Vial is building the first clinical operations platform engineered for true large-scale execution, an integrated system that enables running vastly more trials, activate sites faster, and manage data with unprecedented automation and precision.
Clinical Trials at Massive Scale
We believe massively scalable trial execution will be one of the defining capabilities of the next decade. The speed, reliability, and systemization of Vial empowers us to operate complex portfolios in parallel, reduce operational overhead, and accelerate the development of new therapies.
Focus Areas
Contact
Get in touch!
Compose the future with us
"*" indicates required fields
